MedWorm: Kidney Cancer
- Superior qol with sunitinib in renal cancer
- [cost effectiveness] economic evaluation of sunitinib malate for the first-line treatment of metastatic renal cell carcinoma
- Superior qol with sunitinib in renal cancer.
- Mmp-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by tgf-β1
- Current status of studies on targeted therapy for renal cell carcinoma
- A prospective comparison of laparoscopic and robotic radical nephrectomy for t1-2n0m0 renal cell carcinoma
- Total hla class i loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding β2-microglobulin genes